ShareLab

We are excited to share that our CSO and co-founder Torleif Tollefsrud Gjølberg was recently featured on the "Careers in Discovery" podcast. In this episode, Torleif shares Authera's journey from its roots in the academic community at the University of Oslo and Oslo University Hospital to becoming a revenue-generating biotech innovator, his personal path to becoming a leader in biotech and the challenges and rewards of working in a startup environment focused on scientific discovery. For anyone interested in the leap from academia to biotech or what it takes to build a company with purpose, this episode is a must-listen! Listen here: https://lnkd.in/dqnVfs4t Universitetet i Oslo (UiO) | University of Oslo Oslo University Hospital Jan Terje Andersen ShareLab The Life Science Cluster Innovation Norway Norges forskningsråd Forskningsparken - Oslo Science Park The Antibody Society Tom Froggatt Singular: Building Brilliant Biotechs

We’re #hiring a new SVP Discovery and Early Development in European Union. Apply today or share this post with your network.

Har du en idé innen livsvitenskap som kan løse utfordringer knyttet til menneskers eller dyrs helse? Søk opptak til innovasjonsprogrammet SPARK og lær hvordan videreutvikle innovative ideer til ny teknologi, behandling eller tjeneste. Søknadsfrist 7. november. Universitetet i Oslo (UiO) Veksthuset for verdiskaping – UiO Growth House UiO:Livsvitenskap https://lnkd.in/dtbTKD9F

ShareLab is not just about medical diagnostic and therapy, but also life science. It is soon beerO’clock with Enzyferm’s new excellent range of kveik yeasts. Cheers!

🌟 Exciting News from Caedo Oncology! 🌟 We’re proud to announce that Caedo Oncology has secured 16M NOK in funding from Forskningsrådet (Norwegian Research Council) to advance a novel immunotherapy for B-cell malignancies. The project focuses on: 1.    Better understanding the mechanism of action of CO-1. 2.    A non-GLP safety study in humanized mouse model. 3.    GMP development of the CO-1 fusion protein with our CMO partner. Additionally, we are collaborating with Oslo University Hospital (OUH) to explore the impact of CO-1 on multiple myeloma cells from naïve, relapsed, and refractory patients. This achievement highlights the incredible teamwork and dedication of everyone involved. We’re excited to continue pushing toward better treatments for patients! #Forskningsrådet #Immunotherapy #Cancer #OUH #Innovation.

Today, our Senior Scientist, Gaia Calamera, represented Authera at the "Pitch & Pastries" event hosted by ShareLab. Gaia shared an overview of the work we are doing at Authera, highlighting out platform and our efforts within therapeutic antibody development. It was a great chance to introduce Authera to the community! Many thanks to ShareLab for organizing this event and encouraging knowledge-sharing. The Life Science Cluster Forskningsparken - Oslo Science Park Innovation Norway Norges forskningsråd

🎉 Today at ShareLab, we hosted our very first Pitch & Pastries event! 🥐🎤 What’s better than indulging in delicious pastries while diving into the exciting world of innovation? A huge thank you to Gaia Calamera from Authera, Karin Gilljam from Regenics AS, and Siavash Seifollahy Fakhr from Enzyferm for sharing their insights and expertise. This event is all about building connections and sharing knowledge, and we’re thrilled to see our community come together. Looking forward to more sweet sessions and brilliant concepts in the future! The Life Science Cluster Forskningsparken - Oslo Science Park Innovasjon Norge

Esben A. Nilssen, vår Managing Partner deler sine tanker og erfaringer i MedWatch i dag. Verdt å lese!

SHORT NOTICE: GENE DELIVERY SYMPOSIUM In cooperation with VectorBuilder, we have put together a programme about this increasingly important technology, with a great lineup of speakers. See in comments below. Please register here: https://lnkd.in/dymUqimE

Hva var det biotekinvestorene ikke forstod? Esben A. Nilssen skriver om hvordan man ikke skal gjøre biotekinvesteringer i DN. https://lnkd.in/dFARtUgV